Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sable Offshore Corp.

25.12
-0.8300-3.20%
Post-market: 24.90-0.2200-0.88%18:42 EDT
Volume:1.18M
Turnover:29.83M
Market Cap:2.25B
PE:-2.68
High:26.15
Open:25.55
Low:24.91
Close:25.95
Loading ...

EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…

Zacks Small Cap Research
·
22 Jan

Jefferies Keeps Their Buy Rating on Sable Offshore (SOC)

TIPRANKS
·
21 Jan

Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

Zacks
·
20 Jan

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

PR Newswire
·
17 Jan

Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings

GlobeNewswire
·
17 Jan

US Growth Companies With Up To 29% Insider Ownership

Simply Wall St.
·
16 Jan

Stem to Support 484 MW Hungarian Solar Portfolio in Company’s Largest Software Deal in EMEA

Business Wire
·
14 Jan

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab

Zacks
·
10 Jan

T‑Mobile Stands Prepared as Wildfires Impact Southern California (Updated 1/8)

ACCESSWIRE
·
10 Jan

Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis

PR Newswire
·
09 Jan

GlobalLogic and Hitachi Systems Trusted Cyber Management Open Cutting-Edge Security Operations Center in Poland

Business Wire
·
07 Jan

BRIEF-Sable Offshore Corp Provides Update On Litigation Status

Reuters
·
02 Jan

Sable Offshore provides update on litigation status regarding Haaland lawsuit

TIPRANKS
·
02 Jan

Sable Offshore Corp. Provides Update on Litigation Status

THOMSON REUTERS
·
02 Jan

Sable Offshore Corp: Sable's Operations on Santa Ynez Unit Remain Unaffected

THOMSON REUTERS
·
02 Jan

Sable Offshore Corp. Provides Update on Litigation Status

Business Wire
·
02 Jan